Chunyi Shen

813 total citations
17 papers, 533 citations indexed

About

Chunyi Shen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Chunyi Shen has authored 17 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Chunyi Shen's work include Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chunyi Shen is often cited by papers focused on Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Chunyi Shen collaborates with scholars based in China, United States and Germany. Chunyi Shen's co-authors include Yi Zhang, Yonggui Tian, Liping Wang, Weina Yu, Guohui Qin, Feng Li, Chaoqi Zhang, Dan Wang, Feifei Ren and Qitai Zhao and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Chunyi Shen

17 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunyi Shen China 12 263 232 190 149 91 17 533
Tianxiao Xu China 14 294 1.1× 255 1.1× 107 0.6× 110 0.7× 68 0.7× 29 506
Xile Zhou China 7 193 0.7× 212 0.9× 163 0.9× 76 0.5× 57 0.6× 21 424
Conall Hayes Ireland 8 139 0.5× 247 1.1× 179 0.9× 95 0.6× 76 0.8× 16 447
Sabrina Carpentier France 9 128 0.5× 225 1.0× 372 2.0× 89 0.6× 69 0.8× 11 573
Mingjiong Zhang China 12 275 1.0× 152 0.7× 97 0.5× 227 1.5× 79 0.9× 24 502
Goutham Hassan Venkatesh United Arab Emirates 12 237 0.9× 190 0.8× 97 0.5× 253 1.7× 132 1.5× 18 533
Bo Gong Japan 8 324 1.2× 267 1.2× 129 0.7× 244 1.6× 79 0.9× 9 609
Yuanlin Wu China 11 281 1.1× 118 0.5× 97 0.5× 181 1.2× 77 0.8× 24 469

Countries citing papers authored by Chunyi Shen

Since Specialization
Citations

This map shows the geographic impact of Chunyi Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunyi Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunyi Shen more than expected).

Fields of papers citing papers by Chunyi Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunyi Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunyi Shen. The network helps show where Chunyi Shen may publish in the future.

Co-authorship network of co-authors of Chunyi Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Chunyi Shen. A scholar is included among the top collaborators of Chunyi Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunyi Shen. Chunyi Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tian, Yonggui, Liubo Zhang, Yu P, et al.. (2025). CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors. Cancer Immunology Immunotherapy. 74(2). 55–55. 12 indexed citations
2.
Liu, Shasha, et al.. (2025). Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors. Journal for ImmunoTherapy of Cancer. 13(1). e010540–e010540. 7 indexed citations
3.
Zhang, Zhen, Qitai Zhao, Xinfeng Chen, et al.. (2024). Peripheral Blood–Derived PD-1/CD28–CD19 CAR–Modified PD-1+ T-Cell Therapy in Patients with Solid Tumors. Cancer Immunology Research. 12(12). 1703–1717. 1 indexed citations
4.
Wei, Jing, Ping Yü, Chunyi Shen, et al.. (2023). LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy. OncoImmunology. 13(1). 2293511–2293511. 6 indexed citations
5.
Liu, Yanfen, Zhen Zhang, Yonggui Tian, et al.. (2022). Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma. Cytotherapy. 24(5). 526–533. 3 indexed citations
6.
Huang, Jianmin, Xuan Zhao, Zhen Zhang, et al.. (2022). Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I–II non-small cell lung cancer after curative surgery. Cytotherapy. 25(2). 202–209. 2 indexed citations
7.
Shen, Chunyi, et al.. (2022). Mechanism and strategies of immunotherapy resistance in colorectal cancer. Frontiers in Immunology. 13. 1016646–1016646. 38 indexed citations
8.
P, Yu, Chunyi Shen, Bo Huang, & Yi Zhang. (2022). Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity. Cells. 11(19). 3103–3103. 14 indexed citations
9.
Shen, Chunyi, Zhen Zhang, Yonggui Tian, et al.. (2021). Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway. BMC Medicine. 19(1). 283–283. 26 indexed citations
10.
Zhang, Boya, Mingpeng Zhang, Chunyi Shen, et al.. (2021). LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance. Cell Death and Disease. 12(10). 856–856. 37 indexed citations
11.
12.
Shen, Chunyi, Chaojun Liu, Ping Yü, et al.. (2021). PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer. Frontiers in Immunology. 12. 680055–680055. 20 indexed citations
13.
Shen, Chunyi, Zhen Zhang, & Yi Zhang. (2020). Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies. BioMed Research International. 2020(1). 8765028–8765028. 13 indexed citations
14.
Zhang, Zhen, Feng Li, Yonggui Tian, et al.. (2020). Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK–miR-107–Eomes–PD-1 Pathway. The Journal of Immunology. 204(9). 2575–2588. 108 indexed citations
15.
Zhang, Qingyi, Xuan Zhao, Chaoqi Zhang, et al.. (2019). <p>Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma</p>. Cancer Management and Research. Volume 11. 7813–7824. 34 indexed citations
16.
Zheng, Yujia, et al.. (2018). Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma. Cancer Management and Research. Volume 10. 6079–6096. 60 indexed citations
17.
Zhang, Chaoqi, Zhen Zhang, Liping Wang, et al.. (2017). Pseudomonas aeruginosa -mannose sensitive hemagglutinin injection treated cytokine-induced killer cells combined with chemotherapy in the treatment of malignancies. International Immunopharmacology. 51. 57–65. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianxiao Xu Breakdown of academic impact, for papers by Xile Zhou Breakdown of academic impact, for papers by Conall Hayes Breakdown of academic impact, for papers by Sabrina Carpentier Breakdown of academic impact, for papers by Mingjiong Zhang Breakdown of academic impact, for papers by Goutham Hassan Venkatesh Breakdown of academic impact, for papers by Bo Gong Breakdown of academic impact, for papers by Yuanlin Wu
Rankless by CCL
2026